Management of Psychiatric Disorders in HIV-Infected Patients

  • Author: Glenn J. Treisman, MD, PhD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • Potent ART is the best therapy
    • ART agents have been “scored” for effectiveness in penetrating the nervous system (Table 3)[Letendre 2010] but unclear whether regimens designed to have high CNS penetration confer neurocognitive benefit[Taiwo 2010]
    • Other agents addressing symptoms, such as antidepressants or antianxiety agents, may also be of benefit

Action required

Keywords: Psychiatric Disorders, Special Populations

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.